Simplifying the SLNB Pathway in the NHS: How Magtrace® Tracer Can Improve Theatre and MDT Efficiency

Ever been left frustrated by delays while waiting on a Tc-99m injection?

It is one of the few things that a surgeon cannot control. The injection is booked by another department, the isotope is delivered by a third party, and the whole morning bends around it.

Join three experienced NHS breast surgeons as they discuss how the introduction of the world’s first non-radioactive dual tracer helped them take back control of their schedules. Through real cases, they’ll explore the challenges of working with radioisotopes in the NHS, the practicalities of introducing a non-radioactive solution and the lessons their teams learnt along the way.

​Hear top tips on how best to inject, who can administer it and when, how it can benefit theatre lists, and what the new pathway means for your patients.

Plus, there’s an opportunity to bring your questions during an open audience forum at the end of the webinar.

*Sharat Chopra, Ahmed Mustafa, and Dermot Murphy are paid Hologic consultants. Views and opinions expressed herein by third parties are theirs alone and do not necessarily reflect those of Hologic and its affiliates. This is a general information tool for medical professionals and is not a complete representation of the product Instructions for Use (IFU).